Company Filing History:
Years Active: 2007-2010
Title: The Innovations of Vidar Hansson
Introduction
Vidar Hansson is a notable inventor based in Sandvika, Norway. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of immunodeficiency disorders. With a total of two patents to his name, Hansson's work focuses on innovative methods that aim to improve patient outcomes.
Latest Patents
Hansson's latest patents include groundbreaking methods for treating and preventing AIDS using COX-2 inhibitors. This invention provides a method for administering a COX-2 inhibitor or its derivatives to patients suffering from immunodeficiency disorders, such as HIV. The patent highlights the use of various compounds, including diisopropylfluorophosphate, L-745337, rofecoxib, NS 398, SC 58125, etodolac, meloxicam, celecoxib, and nimesulide, in the preparation of medicaments for treatment. Additionally, he has developed pharmaceutical compositions that utilize immunomodulating agents capable of inhibiting cAMP-dependent protein kinase A (PKA) for treating immunosuppressive diseases.
Career Highlights
Hansson is currently associated with Lauras AS, where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential to change the landscape of treatment for diseases that compromise the immune system.
Collaborations
Hansson has collaborated with notable colleagues, including Kjetil Taskén and Einar Martin Aandahl. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
Vidar Hansson's contributions to the field of immunology and pharmaceuticals are noteworthy. His innovative patents reflect a commitment to improving treatment options for patients with immunodeficiency disorders. His work continues to inspire advancements in medical science.